Association of PPAR ß/d- 87T>C Polymorphism with the Risk of Colorectal Cancer in Chinese Han population

Relationship of PPARd-87T>C Polymorphism with Colorectal Cancer Risk in a Chinese Han Population

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100054751

Enrollment

Unknown

Registered

2021-12-26

Start date

2021-01-01

Completion date

Unknown

Last updated

2022-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

primary colorectal cancer group VS healthy control group:no intervention

Eligibility

Sex/Gender

All

Age

17 Years to 91 Years

Inclusion criteria

Inclusion criteria: Colorectal cancer patients from the Institute of Gastrointestinal Surgery, West China Hospital, Sichuan University (primary colorectal cancer underwent surgical resection, all confirmed by histopathology), Han population in the southwest region; no blood relationship.

Exclusion criteria

Exclusion criteria: 1. Preoperative radiotherapy and chemotherapy; history of long-term use of non-steroidal anti-inflammatory drugs; 2. Patients with incomplete clinical data; familial adenomatous polyposis and hereditary non-polyposis colorectal cancer; 3. Patients with other cancers in the past; patients with first-degree relatives suffering from colorectal cancer.

Design outcomes

Primary

Measure	Time frame
Peroxisome proliferator-activated receptor delta-87T>C;	—

Countries

China

Contacts

Public ContactYang Lie

West China Hospital, Sichuan University

lie_222@163.com+86 28 85553329

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026